Franz Gerner
Independent Consultant of South Mountain Advanced Therapies Consultants
Franz has been working in the Gene Therapy field for more than 20 years, optimizing the manufacturing and of adeno associated viral vectors. He has started his career at the Max-Planck-Institute for Virology and the testing Gene Center of the University of Munich, where he received his Ph.D. After working on a gene therapy project at Wellstat Ophthalmics and subsequently at a Contract Manufacturer, he joined REGENXBIO Inc. 4 years ago. Until recently he led the Process Development group, and has transitioned within the company to lead the newly established Technical Innovations and New Technologies group. His focus has been the development of a robust and scalable manufacturing platform with increased titer and quality while addressing to decrease the cost of goods.



Speakers

















































